Viemed Healthcare Beheer
Beheer criteriumcontroles 3/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Casey Hoyt
Algemeen directeur
US$1.9m
Totale compensatie
| Percentage CEO-salaris | 24.4% |
| Dienstverband CEO | 6yrs |
| Eigendom CEO | 5.6% |
| Management gemiddelde ambtstermijn | 6yrs |
| Gemiddelde ambtstermijn bestuur | 6yrs |
Recente managementupdates
Recent updates
Is Viemed Healthcare (TSE:VMD) A Risky Investment?
Sep 13
The Returns On Capital At Viemed Healthcare (TSE:VMD) Don't Inspire Confidence
May 27Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Feb 18Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Oct 27Some Investors May Be Worried About Viemed Healthcare's (TSE:VMD) Returns On Capital
Jul 08Does This Valuation Of Viemed Healthcare, Inc. (TSE:VMD) Imply Investors Are Overpaying?
Mar 10These 4 Measures Indicate That Viemed Healthcare (TSE:VMD) Is Using Debt Reasonably Well
Dec 09Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why
Jun 04Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt
May 18Viemed Healthcare, Inc.'s (TSE:VMD) Stock Is Going Strong: Is the Market Following Fundamentals?
Mar 03I Ran A Stock Scan For Earnings Growth And Viemed Healthcare (TSE:VMD) Passed With Ease
Feb 16Viemed Healthcare (TSE:VMD) Seems To Use Debt Rather Sparingly
Feb 03If You Had Bought Viemed Healthcare (TSE:VMD) Shares Three Years Ago You'd Have Earned 319% Returns
Jan 21
Did Viemed Healthcare, Inc. (TSE:VMD) Insiders Sell Shares?
Jan 08Should You Rely On Viemed Healthcare's (TSE:VMD) Earnings Growth?
Dec 22Declining Stock and Solid Fundamentals: Is The Market Wrong About Viemed Healthcare, Inc. (TSE:VMD)?
Nov 25Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | US$9m |
| Jun 30 2023 | n/a | n/a | US$7m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$2m | US$470k | US$6m |
| Sep 30 2022 | n/a | n/a | US$8m |
| Jun 30 2022 | n/a | n/a | US$9m |
| Mar 31 2022 | n/a | n/a | US$9m |
| Dec 31 2021 | US$2m | US$470k | US$9m |
| Sep 30 2021 | n/a | n/a | US$10m |
| Jun 30 2021 | n/a | n/a | US$11m |
| Mar 31 2021 | n/a | n/a | US$29m |
| Dec 31 2020 | US$2m | US$441k | US$32m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$29m |
| Mar 31 2020 | n/a | n/a | US$11m |
| Dec 31 2019 | US$2m | US$425k | US$9m |
| Sep 30 2019 | n/a | n/a | US$9m |
| Jun 30 2019 | n/a | n/a | US$8m |
| Mar 31 2019 | n/a | n/a | US$9m |
| Dec 31 2018 | US$2m | US$389k | US$10m |
| Sep 30 2018 | n/a | n/a | US$7m |
| Jun 30 2018 | n/a | n/a | US$9m |
| Mar 31 2018 | n/a | n/a | US$8m |
| Dec 31 2017 | US$1m | US$235k | US$8m |
| Sep 30 2017 | n/a | n/a | US$11m |
| Dec 31 2016 | US$231k | US$227k | US$1m |
Compensatie versus markt: Casey's total compensation ($USD1.93M) is above average for companies of similar size in the Canadian market ($USD742.49K).
Compensatie versus inkomsten: Casey's compensation has been consistent with company performance over the past year.
CEO
Casey Hoyt (46 yo)
6yrs
Tenure
US$1,925,507
Compensatie
Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and Chief Executive Officer since December 2017. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Co...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 6yrs | US$1.93m | 5.59% CA$ 17.4m | |
| President | 6yrs | US$1.48m | 4.72% CA$ 14.7m | |
| Chief Financial Officer | 6yrs | US$628.81k | 0.15% CA$ 459.9k | |
| COO & Director | 6yrs | US$1.47m | 0.50% CA$ 1.6m | |
| Chief Medical Officer & Director | 6yrs | US$341.94k | 0.17% CA$ 527.2k | |
| Chief Legal Officer and Executive VP of Acquisitions & Strategic Transactions | 1.3yrs | geen gegevens | 0.0098% CA$ 30.7k | |
| Chief Business Development Officer | 1.3yrs | geen gegevens | geen gegevens | |
| General Counsel & Corporate Secretary | 2.5yrs | geen gegevens | 0% CA$ 0 |
6.0yrs
Gemiddelde duur
45.5yo
Gemiddelde leeftijd
Ervaren management: VMD's management team is seasoned and experienced (6 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 7yrs | US$1.93m | 5.59% CA$ 17.4m | |
| COO & Director | 6yrs | US$1.47m | 0.50% CA$ 1.6m | |
| Chief Medical Officer & Director | 6yrs | US$341.94k | 0.17% CA$ 527.2k | |
| Independent Chairman | 6yrs | US$213.07k | 0.25% CA$ 770.3k | |
| Independent Director | 6yrs | US$193.22k | 0.30% CA$ 940.6k | |
| Independent Director | 3.1yrs | US$182.22k | 0.099% CA$ 309.6k | |
| Independent Director | 6yrs | US$190.22k | 0.21% CA$ 655.5k | |
| Independent Director | 5.4yrs | US$190.85k | 0.17% CA$ 534.0k |
6.0yrs
Gemiddelde duur
57.5yo
Gemiddelde leeftijd
Ervaren bestuur: VMD's board of directors are considered experienced (6 years average tenure).